SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001628280-22-004526
Filing Date
2022-03-01
Accepted
2022-03-01 16:25:17
Documents
80
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ngm-20211231.htm   iXBRL 10-K 2458417
2 EX-10.23 ngm-20211231x10kex1023.htm EX-10.23 39721
3 EX-21.1 ngm-20211231x10kex211.htm EX-21.1 2699
4 EX-23.1 ngm-20211231x10kex231.htm EX-23.1 4263
5 EX-31.1 ngm-20211231x10kex311.htm EX-31.1 10634
6 EX-31.2 ngm-20211231x10kex312.htm EX-31.2 10317
7 EX-32.1 ngm-20211231x10kex321.htm EX-32.1 7035
13 GRAPHIC image_0a.jpg GRAPHIC 19532
14 GRAPHIC lonzalogoa.jpg GRAPHIC 18271
15 GRAPHIC ngm-20211231_g1.jpg GRAPHIC 217731
16 GRAPHIC ngm-20211231_g2.jpg GRAPHIC 86474
  Complete submission text file 0001628280-22-004526.txt   9945906

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngm-20211231.xsd EX-101.SCH 55653
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngm-20211231_cal.xml EX-101.CAL 77025
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngm-20211231_def.xml EX-101.DEF 246567
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngm-20211231_lab.xml EX-101.LAB 705650
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngm-20211231_pre.xml EX-101.PRE 449582
74 EXTRACTED XBRL INSTANCE DOCUMENT ngm-20211231_htm.xml XML 1401447
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38853 | Film No.: 22698474
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences